Penumbra Inc

Research Penumbra Inc (PEN) on Bullrun: valuation model: 6.7% overvalued, market cap USD 12.41B, P/E 72.6. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPEN
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Valuation signal6.7% overvalued
• Market capUSD 12.41B
• P/E72.6
• Financial periodFY2025
• RevenueUSD 1.40B
• Revenue growth17.5%
• Net incomeUSD 177.69M
• Free cash flowUSD 174.93M
• Gross margin67.1%

Valuation Snapshot

Bullrun's latest valuation model marks Penumbra Inc as 6.7% overvalued; latest market cap is USD 12.41B; P/E is 72.6.

About Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.

Frequently asked questions

Is Penumbra Inc overvalued or undervalued?

Bullrun's valuation model currently marks Penumbra Inc as 6.7% overvalued.

What is Penumbra Inc's market cap?

Penumbra Inc's market capitalization is USD 12.41B.

What is Penumbra Inc's P/E ratio?

Penumbra Inc's price-to-earnings (P/E) ratio is 72.6.

What does Penumbra Inc do?

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy;